A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

June 15, 2021

Study Completion Date

June 28, 2021

Conditions
Smoking Cessation
Interventions
DRUG

BR9003 2mg

After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003 tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it.

DRUG

BR9003A 1mg

After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003A tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it. Another BR9003A tablet will be administered orally with water 150mL around 20:30 after dinner between 18-19:00.

Trial Locations (1)

Unknown

Inha University Hospital, Incheon

All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY